An Aussie health company that exploded during the Covid pandemic thanks to PCR testing has laid off hundreds of workers as the nation moves towards living with the virus.
Healthcare company Healius, which is the pathology arm of Specialist Diagnostic Services, is one of Australia’s leading providers of private medical and berkah anak yatim lab services.
The company saw huge success during the pandemic but with less and less people getting PCR tests, it announced on Monday it was cutting 500 full-time roles due to ‘natural attrition’.
The cuts equate to around 13 per cent of its 6500-strong workforce.
The ASX-listed company offers pathology and imaging services and helped establish and run a number of drive-through Covid-19 PCR testing collection centres.
Healthcare company Healius has scaled back its business as Australia learns to live with coronavirus (stock image pictured)
In 2020, Healius’ first quarter revenue rose to $689.9million from $480.2million, and its earnings almost tripled to $201.9m.
A Healius spokesperson said the 500 job losses were related to both ‘natural attrition and redundancies’ and the cuts meant its workforce had returned to the size it was back in 2019 – before the pandemic started in early 2020.
The spokesperson told